SCHEMBL7989336

SCHEMBL7989336

C[C@@H]1Oc2ccc(Cl)cc2N=C1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 2/20 0.42
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
HRH4 Q9H3N8 5/20 0.36
DRD4 P21917 2/20 0.35
DRD2 P14416 1/20 0.35
AHR P35869 3/20 0.34
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
CYP3A4 P08684 2/20 0.32
NR3C1 P04150 1/20 0.32
PGR P06401 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984721 1.00 MAPT (0.43) MAPTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL7985549 1.00 MAPT (0.43) MAPTSMN1; SMN2NPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL7980991 0.98 MAPT (0.42) MAPTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL7985616 0.93 MAPT (0.47) MAPTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL7985025 0.83 MAPK1 (0.44) MAPTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL5671427 0.81 NOS3 (0.43) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL6993351 0.81 NOS3 (0.42) SMN1; SMN2MEN1KMT2AMAPK1NOS3
Hydrochloric Acid SCHEMBL6996690 0.80 NOS3 (0.44) SMN1; SMN2MEN1KMT2AMAPK1NOS3
SCHEMBL7002475 0.78 NOS3 (0.55) NOS3NOS1NOS2CYP3A4
Hydrochloric Acid SCHEMBL7004141 0.77 NOS1 (0.57) NOS3NOS1NOS2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191127-B1 ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed